img

Global Pharmacokinetics Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Pharmacokinetics Market Research Report 2024

Pharmacokinetics is a branch of pharmacology dedicated to determining the fate of substances administered to a living organism.
According to MRAResearch’s new survey, global Pharmacokinetics market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharmacokinetics market research.
Pharmacokinetics describes how the body affects a specific chemical after administration through the mechanisms of absorption and distribution, as well as the metabolic changes of the substance in the body, and the effects and routes of excretion of the metabolites of the drug.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Pharmacokinetics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Charles River Laboratories
Covance
Cyprotex
Drumetix Laboratories
Eurofins Scientific
GVK Biosciences
LGC
Parexel
Pharmoptima
TCG Lifesciences
Segment by Type
Noncompartmental Methods
Compartmental Methods

Segment by Application


Oncology
Cardiovascular Diseases
Infectious Diseases
Autoimmune Diseases
Respiratory Disorders
Neurological Disorders
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Pharmacokinetics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacokinetics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Noncompartmental Methods
1.2.3 Compartmental Methods
1.3 Market by Application
1.3.1 Global Pharmacokinetics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Oncology
1.3.3 Cardiovascular Diseases
1.3.4 Infectious Diseases
1.3.5 Autoimmune Diseases
1.3.6 Respiratory Disorders
1.3.7 Neurological Disorders
1.3.8 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacokinetics Market Perspective (2018-2033)
2.2 Pharmacokinetics Growth Trends by Region
2.2.1 Global Pharmacokinetics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Pharmacokinetics Historic Market Size by Region (2018-2023)
2.2.3 Pharmacokinetics Forecasted Market Size by Region (2024-2033)
2.3 Pharmacokinetics Market Dynamics
2.3.1 Pharmacokinetics Industry Trends
2.3.2 Pharmacokinetics Market Drivers
2.3.3 Pharmacokinetics Market Challenges
2.3.4 Pharmacokinetics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacokinetics Players by Revenue
3.1.1 Global Top Pharmacokinetics Players by Revenue (2018-2023)
3.1.2 Global Pharmacokinetics Revenue Market Share by Players (2018-2023)
3.2 Global Pharmacokinetics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacokinetics Revenue
3.4 Global Pharmacokinetics Market Concentration Ratio
3.4.1 Global Pharmacokinetics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacokinetics Revenue in 2022
3.5 Pharmacokinetics Key Players Head office and Area Served
3.6 Key Players Pharmacokinetics Product Solution and Service
3.7 Date of Enter into Pharmacokinetics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacokinetics Breakdown Data by Type
4.1 Global Pharmacokinetics Historic Market Size by Type (2018-2023)
4.2 Global Pharmacokinetics Forecasted Market Size by Type (2024-2033)
5 Pharmacokinetics Breakdown Data by Application
5.1 Global Pharmacokinetics Historic Market Size by Application (2018-2023)
5.2 Global Pharmacokinetics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Pharmacokinetics Market Size (2018-2033)
6.2 North America Pharmacokinetics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Pharmacokinetics Market Size by Country (2018-2023)
6.4 North America Pharmacokinetics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacokinetics Market Size (2018-2033)
7.2 Europe Pharmacokinetics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Pharmacokinetics Market Size by Country (2018-2023)
7.4 Europe Pharmacokinetics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacokinetics Market Size (2018-2033)
8.2 Asia-Pacific Pharmacokinetics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Pharmacokinetics Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmacokinetics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacokinetics Market Size (2018-2033)
9.2 Latin America Pharmacokinetics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Pharmacokinetics Market Size by Country (2018-2023)
9.4 Latin America Pharmacokinetics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacokinetics Market Size (2018-2033)
10.2 Middle East & Africa Pharmacokinetics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Pharmacokinetics Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmacokinetics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories Pharmacokinetics Introduction
11.1.4 Charles River Laboratories Revenue in Pharmacokinetics Business (2018-2023)
11.1.5 Charles River Laboratories Recent Development
11.2 Covance
11.2.1 Covance Company Detail
11.2.2 Covance Business Overview
11.2.3 Covance Pharmacokinetics Introduction
11.2.4 Covance Revenue in Pharmacokinetics Business (2018-2023)
11.2.5 Covance Recent Development
11.3 Cyprotex
11.3.1 Cyprotex Company Detail
11.3.2 Cyprotex Business Overview
11.3.3 Cyprotex Pharmacokinetics Introduction
11.3.4 Cyprotex Revenue in Pharmacokinetics Business (2018-2023)
11.3.5 Cyprotex Recent Development
11.4 Drumetix Laboratories
11.4.1 Drumetix Laboratories Company Detail
11.4.2 Drumetix Laboratories Business Overview
11.4.3 Drumetix Laboratories Pharmacokinetics Introduction
11.4.4 Drumetix Laboratories Revenue in Pharmacokinetics Business (2018-2023)
11.4.5 Drumetix Laboratories Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Detail
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific Pharmacokinetics Introduction
11.5.4 Eurofins Scientific Revenue in Pharmacokinetics Business (2018-2023)
11.5.5 Eurofins Scientific Recent Development
11.6 GVK Biosciences
11.6.1 GVK Biosciences Company Detail
11.6.2 GVK Biosciences Business Overview
11.6.3 GVK Biosciences Pharmacokinetics Introduction
11.6.4 GVK Biosciences Revenue in Pharmacokinetics Business (2018-2023)
11.6.5 GVK Biosciences Recent Development
11.7 LGC
11.7.1 LGC Company Detail
11.7.2 LGC Business Overview
11.7.3 LGC Pharmacokinetics Introduction
11.7.4 LGC Revenue in Pharmacokinetics Business (2018-2023)
11.7.5 LGC Recent Development
11.8 Parexel
11.8.1 Parexel Company Detail
11.8.2 Parexel Business Overview
11.8.3 Parexel Pharmacokinetics Introduction
11.8.4 Parexel Revenue in Pharmacokinetics Business (2018-2023)
11.8.5 Parexel Recent Development
11.9 Pharmoptima
11.9.1 Pharmoptima Company Detail
11.9.2 Pharmoptima Business Overview
11.9.3 Pharmoptima Pharmacokinetics Introduction
11.9.4 Pharmoptima Revenue in Pharmacokinetics Business (2018-2023)
11.9.5 Pharmoptima Recent Development
11.10 TCG Lifesciences
11.10.1 TCG Lifesciences Company Detail
11.10.2 TCG Lifesciences Business Overview
11.10.3 TCG Lifesciences Pharmacokinetics Introduction
11.10.4 TCG Lifesciences Revenue in Pharmacokinetics Business (2018-2023)
11.10.5 TCG Lifesciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pharmacokinetics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Noncompartmental Methods
Table 3. Key Players of Compartmental Methods
Table 4. Global Pharmacokinetics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Pharmacokinetics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Pharmacokinetics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Pharmacokinetics Market Share by Region (2018-2023)
Table 8. Global Pharmacokinetics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Pharmacokinetics Market Share by Region (2024-2033)
Table 10. Pharmacokinetics Market Trends
Table 11. Pharmacokinetics Market Drivers
Table 12. Pharmacokinetics Market Challenges
Table 13. Pharmacokinetics Market Restraints
Table 14. Global Pharmacokinetics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Pharmacokinetics Market Share by Players (2018-2023)
Table 16. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics as of 2022)
Table 17. Ranking of Global Top Pharmacokinetics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Pharmacokinetics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacokinetics Product Solution and Service
Table 21. Date of Enter into Pharmacokinetics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacokinetics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Pharmacokinetics Revenue Market Share by Type (2018-2023)
Table 25. Global Pharmacokinetics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Pharmacokinetics Revenue Market Share by Type (2024-2033)
Table 27. Global Pharmacokinetics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Pharmacokinetics Revenue Market Share by Application (2018-2023)
Table 29. Global Pharmacokinetics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Pharmacokinetics Revenue Market Share by Application (2024-2033)
Table 31. North America Pharmacokinetics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Pharmacokinetics Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Pharmacokinetics Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Pharmacokinetics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Pharmacokinetics Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Pharmacokinetics Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Pharmacokinetics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Pharmacokinetics Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Pharmacokinetics Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Pharmacokinetics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Pharmacokinetics Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Pharmacokinetics Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Pharmacokinetics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Pharmacokinetics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Pharmacokinetics Market Size by Country (2024-2033) & (US$ Million)
Table 46. Charles River Laboratories Company Detail
Table 47. Charles River Laboratories Business Overview
Table 48. Charles River Laboratories Pharmacokinetics Product
Table 49. Charles River Laboratories Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 50. Charles River Laboratories Recent Development
Table 51. Covance Company Detail
Table 52. Covance Business Overview
Table 53. Covance Pharmacokinetics Product
Table 54. Covance Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 55. Covance Recent Development
Table 56. Cyprotex Company Detail
Table 57. Cyprotex Business Overview
Table 58. Cyprotex Pharmacokinetics Product
Table 59. Cyprotex Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 60. Cyprotex Recent Development
Table 61. Drumetix Laboratories Company Detail
Table 62. Drumetix Laboratories Business Overview
Table 63. Drumetix Laboratories Pharmacokinetics Product
Table 64. Drumetix Laboratories Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 65. Drumetix Laboratories Recent Development
Table 66. Eurofins Scientific Company Detail
Table 67. Eurofins Scientific Business Overview
Table 68. Eurofins Scientific Pharmacokinetics Product
Table 69. Eurofins Scientific Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 70. Eurofins Scientific Recent Development
Table 71. GVK Biosciences Company Detail
Table 72. GVK Biosciences Business Overview
Table 73. GVK Biosciences Pharmacokinetics Product
Table 74. GVK Biosciences Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 75. GVK Biosciences Recent Development
Table 76. LGC Company Detail
Table 77. LGC Business Overview
Table 78. LGC Pharmacokinetics Product
Table 79. LGC Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 80. LGC Recent Development
Table 81. Parexel Company Detail
Table 82. Parexel Business Overview
Table 83. Parexel Pharmacokinetics Product
Table 84. Parexel Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 85. Parexel Recent Development
Table 86. Pharmoptima Company Detail
Table 87. Pharmoptima Business Overview
Table 88. Pharmoptima Pharmacokinetics Product
Table 89. Pharmoptima Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 90. Pharmoptima Recent Development
Table 91. TCG Lifesciences Company Detail
Table 92. TCG Lifesciences Business Overview
Table 93. TCG Lifesciences Pharmacokinetics Product
Table 94. TCG Lifesciences Revenue in Pharmacokinetics Business (2018-2023) & (US$ Million)
Table 95. TCG Lifesciences Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacokinetics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Pharmacokinetics Market Share by Type: 2022 VS 2033
Figure 3. Noncompartmental Methods Features
Figure 4. Compartmental Methods Features
Figure 5. Global Pharmacokinetics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Pharmacokinetics Market Share by Application: 2022 VS 2033
Figure 7. Oncology Case Studies
Figure 8. Cardiovascular Diseases Case Studies
Figure 9. Infectious Diseases Case Studies
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Respiratory Disorders Case Studies
Figure 12. Neurological Disorders Case Studies
Figure 13. Others Case Studies
Figure 14. Pharmacokinetics Report Years Considered
Figure 15. Global Pharmacokinetics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global Pharmacokinetics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global Pharmacokinetics Market Share by Region: 2022 VS 2033
Figure 18. Global Pharmacokinetics Market Share by Players in 2022
Figure 19. Global Top Pharmacokinetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetics as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Pharmacokinetics Revenue in 2022
Figure 21. North America Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America Pharmacokinetics Market Share by Country (2018-2033)
Figure 23. United States Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Canada Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Pharmacokinetics Market Share by Country (2018-2033)
Figure 27. Germany Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. France Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. U.K. Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Italy Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Russia Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Nordic Countries Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Pharmacokinetics Market Share by Region (2018-2033)
Figure 35. China Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Japan Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. South Korea Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Southeast Asia Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. India Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Australia Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Pharmacokinetics Market Share by Country (2018-2033)
Figure 43. Mexico Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Brazil Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Pharmacokinetics Market Share by Country (2018-2033)
Figure 47. Turkey Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Saudi Arabia Pharmacokinetics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Charles River Laboratories Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 50. Covance Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 51. Cyprotex Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 52. Drumetix Laboratories Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 53. Eurofins Scientific Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 54. GVK Biosciences Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 55. LGC Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 56. Parexel Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 57. Pharmoptima Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 58. TCG Lifesciences Revenue Growth Rate in Pharmacokinetics Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed